We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use A/B testing to evaluate your digital health product.
Decision for applicant Barclays Bank Plc against registration number 15117504, applicant successful.
Public health principles for reducing the spread of respiratory infections, including COVID-19, in the workplace.
To help you protect, manage and enforce your intellectual property (IP) rights in Vietnam.
The CMA investigated alleged excessive and unfair pricing, anti-competitive agreements and abusive conduct with respect to hydrocortisone tablets under Chapters I and II CA98 and Articles 101 and 102 TFEU.
Guidance on the decentralised and mutual recognition reliance procedure (MRDCRP) for marketing authorisation applications including information on how to apply.
The Company Names Tribunal practice direction provides the framework for the management of proceedings brought before the Tribunal.
Use a separate statement of objection form for each Japanese GI product name you object to.
A speech by Marcus Bokkerink, Chair of the Competition and Markets Authority (CMA), delivered at the CMA's 10 year anniversary event.
Information to help you protect, manage and enforce your intellectual property (IP) rights in Malaysia.
Information to help you protect, manage and enforce your intellectual property (IP) rights in Indonesia.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Find out about gaining approval for a fair partial exemption special method if you deal with partial exemption for insurers.
A speech by Sarah Cardell, CEO of the Competition and Markets Authority (CMA), delivered at the CMA's 10 year anniversary event.
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
How to use routinely collected data to evaluate your digital health product.
Overview of the Civil Service Jobs vX system for recruiters, including search and table layouts.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.